[Featured Stock] Cheonlab Acquired by CJ CheilJedang Hits Upper Limit Early in Trading
[Asia Economy Reporter Park Soyeon] CheonLab is hitting the upper price limit in early trading.
As of 9:39 AM on the 22nd, CheonLab is trading at 64,200 KRW on the KOSDAQ market, up 14,800 KRW (29.96%) from the previous day.
On the previous day, CJ CheilJedang announced its acquisition of CheonLab. The acquisition amount is approximately 98.3 billion KRW, securing a 44% stake by combining CheonLab's existing shares and new shares issued through a paid-in capital increase.
CheonLab's market capitalization is 251 billion KRW, ranking 434th on KOSDAQ. The number of listed shares is 3,909,848.
Founded in 2009, the company primarily operates microbial life information analysis services and microbiome-based healthcare services through a microbiome big data platform.
Using a precision classification platform, it provides microbial genome life information analysis platforms and solutions, as well as microbiome-based customized healthcare services.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Microbiome is a term combining Microbe and Biome, referring to the tens of trillions of microbes and their genes existing within the human body.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
